214 related articles for article (PubMed ID: 30666110)
1. Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells.
Abdelaziz HM; Elzoghby AO; Helmy MW; Samaha MW; Fang JY; Freag MS
Int J Nanomedicine; 2019; 14():499-517. PubMed ID: 30666110
[TBL] [Abstract][Full Text] [Related]
2. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
[TBL] [Abstract][Full Text] [Related]
3. Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.
Jain S; Bhankur N; Swarnakar NK; Thanki K
Pharm Res; 2015 Oct; 32(10):3282-92. PubMed ID: 25968624
[TBL] [Abstract][Full Text] [Related]
4. Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation.
Badie H; Abbas H
Drug Dev Ind Pharm; 2018 Dec; 44(12):2013-2025. PubMed ID: 30095009
[TBL] [Abstract][Full Text] [Related]
5. Layer-by-layer-coated lyotropic liquid crystalline nanoparticles for active tumor targeting of rapamycin.
Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
Nanomedicine (Lond); 2016 Nov; 11(22):2975-2996. PubMed ID: 27785978
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma.
Nisha R; Kumar P; Kumar U; Mishra N; Maurya P; Singh S; Singh P; Guleria A; Saha S; Saraf SA
Mol Pharm; 2021 Mar; 18(3):1102-1120. PubMed ID: 33356314
[TBL] [Abstract][Full Text] [Related]
7. Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management.
Freag MS; Torky AS; Nasra MM; Abdelmonsif DA; Abdallah OY
Nanomedicine (Lond); 2019 Apr; 14(8):931-954. PubMed ID: 30925102
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery.
Elgindy NA; Mehanna MM; Mohyeldin SM
Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671
[TBL] [Abstract][Full Text] [Related]
9. Inhalable Lactoferrin/Chondroitin-Functionalized Monoolein Nanocomposites for Localized Lung Cancer Targeting.
Abdelaziz HM; Elzoghby AO; Helmy MW; Abdelfattah EA; Fang JY; Samaha MW; Freag MS
ACS Biomater Sci Eng; 2020 Feb; 6(2):1030-1042. PubMed ID: 33464839
[TBL] [Abstract][Full Text] [Related]
10. A synergistic approach for management of lung carcinoma through folic acid functionalized co-therapy of capsaicin and gefitinib nanoparticles: Enhanced apoptosis and metalloproteinase-9 down-regulation.
Parashar P; Tripathi CB; Arya M; Kanoujia J; Singh M; Yadav A; Kaithwas G; Saraf SA
Phytomedicine; 2019 Feb; 53():107-123. PubMed ID: 30668390
[TBL] [Abstract][Full Text] [Related]
11. Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy.
Chen J; Yang X; Huang L; Lai H; Gan C; Luo X
Drug Deliv; 2018 Nov; 25(1):1932-1942. PubMed ID: 30472899
[TBL] [Abstract][Full Text] [Related]
12. Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement.
Jain S; Yadav P; Swami R; Swarnakar NK; Kushwah V; Katiyar SS
AAPS PharmSciTech; 2018 May; 19(4):1699-1711. PubMed ID: 29532426
[TBL] [Abstract][Full Text] [Related]
13. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed.
Ando H; Kobayashi S; Abu Lila AS; Eldin NE; Kato C; Shimizu T; Ukawa M; Kawazoe K; Ishida T
J Control Release; 2015 Dec; 220(Pt A):29-36. PubMed ID: 26476173
[TBL] [Abstract][Full Text] [Related]
14. Liposomal pemetrexed: formulation, characterization and in vitro cytotoxicity studies for effective management of malignant pleural mesothelioma.
Essam Eldin N; Elnahas HM; Mahdy MA; Ishida T
Biol Pharm Bull; 2015; 38(3):461-9. PubMed ID: 25757929
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model.
Eldin NE; Abu Lila AS; Kawazoe K; Elnahas HM; Mahdy MA; Ishida T
Eur J Pharm Sci; 2016 Jan; 81():60-6. PubMed ID: 26415830
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.
Pangeni R; Choi JU; Panthi VK; Byun Y; Park JW
Int J Nanomedicine; 2018; 13():3329-3351. PubMed ID: 29922055
[TBL] [Abstract][Full Text] [Related]
17. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.
Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822
[TBL] [Abstract][Full Text] [Related]
18. Study on co-delivery of pemetrexed disodium and Bcl-2 siRNA by poly-γ-glutamic acid-modified cationic liposomes for the inhibition of NSCLC.
Huang X; Song R; Wang X; He K; Shan R; Xie F; Huang G
Drug Dev Ind Pharm; 2023 Jan; 49(1):62-74. PubMed ID: 36803267
[TBL] [Abstract][Full Text] [Related]
19. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes.
Barauskas J; Cervin C; Jankunec M; Spandyreva M; Ribokaite K; Tiberg F; Johnsson M
Int J Pharm; 2010 May; 391(1-2):284-91. PubMed ID: 20214966
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Evaluation of Stearylamine-Bearing Pemetrexed Disodium-Loaded Cationic Liposomes In Vitro and In Vivo.
He K; Liu J; Gao Y; Hao Y; Yang X; Huang G
AAPS PharmSciTech; 2020 Jul; 21(5):193. PubMed ID: 32661922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
